LOINCActiveBoth

LOINC Code 102003-1: Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase

102003-1 is a LOINC code used to identify Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Reduction in clot strength. It is commonly used with the system or sample type Bld.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Reduction in clot strength. It is commonly used with the system or sample type Bld.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Thromboelastography.kaolin induced.30M after maximum clot amplitude after addition of heparinase

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase
  • Reduction in clot strength
  • Blood; COAGULATION; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinaseRd.clot.kaolin.ind 30M p MA hep LenFr BReduction in clot strengthCOAGLenFrPtBld

Frequently asked questions

Code details

Code102003-1
SystemLOINC
Display nameReduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase
DescriptionReduction in clot strength
Short nameRd.clot.kaolin.ind 30M p MA hep LenFr B
ComponentReduction in clot strength
PropertyLenFr
TimingPt
System (specimen)Bld
ScaleQn
MethodThromboelastography.kaolin induced.30M after maximum clot amplitude after addition of heparinase
ClassCOAG
Example units%
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.75
Last changed2.82

Consumer names

Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase

Part names

Reduction in clot strengthLenFrPtBldQnThromboelastography.kaolin induced.30M after maximum clot amplitude after addition of heparinaseLength fractionPoint in time (spot)Blood

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

LOINC Code 102003-1 | HealthAssure